Arnado, Jenevive .

HRN: 22-45-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
CEFTRIAXONE 1G (VIAL)
12/15/2023
12/22/2023
IVT
2 Gm
Q 24h
Acute Pyelonephritis; G4P3 (3003)
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: